“CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY”, PharmaNexus Bull, vol. 2, no. 2, pp. 1–5, Jul. 2026, Accessed: Aug. 27, 2026. [Online]. Available: https://lapinjournals.com/index.php/pnb/article/view/208